Riskpilot← Back to searchSign inGet full accessSYV8SEKS AS
ASActiveOrg 998778891Funkelveien 12, 1900 FetsundGeneral medical practice activities · NACE 8621Est. 20121 employees
Revenue 2024
NOK 3,2M
+2% vs 2023
EBITDA margin
13.0%
+28% vs 2023
Equity ratio
55.4%
Financial strength
Net profit 2024
NOK 332K
+40% vs 2023
| Revenue | NOK 3,2M | +2% |
| EBITDA | NOK 419K | +28% |
| Net profit | NOK 332K | +40% |
| Total assets | NOK 1,2M | -28% |
| Equity | NOK 669K | +99% |
| Employees | 1 | — |
Legal name
SYV8SEKS AS
Org number
998778891
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
1. september 2012
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Legevirksomhet, undervisning, deltakelse i andre selskap og annen investeringsvirksomhet.
Address
Funkelveien 12, 1900 Fetsund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 718 | 2 703 | 2 678 | 3 174 | 3 225 |
| Staff expenses | −496 | −1 483 | −1 633 | −1 532 | −1 477 |
| EBITDA | 321 | 363 | 11 | 327 | 419 |
| Depreciation & amort. | −144 | −74 | −74 | −44 | −0 |
| EBIT | 177 | 289 | −63 | 284 | 419 |
| Net financials | −14 | −16 | −18 | −40 | −2 |
| Profit before tax | 164 | 272 | −81 | 243 | 417 |
| Tax | 49 | 64 | −0 | 6 | 85 |
| Net profit | 115 | 209 | −81 | 237 | 332 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 654 | 940 | 646 | 1 685 | 1 207 |
| Equity | 72 | 281 | 200 | 337 | 669 |
| Long-term debt | 245 | 205 | 145 | 941 | −70 |
| Short-term debt | 337 | 454 | 301 | 407 | 609 |
| Total debt | 582 | 659 | 446 | 1 348 | 538 |
EBITDA margin
13.0%
This company
15.8%
Market median
-18% vs market
20202024
Equity ratio
55.4%
This company
38.2%
Market median
+45% vs market
20202024
Return on equity
49.6%
This company
18.4%
Market median
+170% vs market
20202024
Net profit margin
10.3%
This company
8.1%
Market median
+27% vs market
20202024
Asset turnover
2.67×
This company
1.12×
Market median
+138% vs market
20202024
Debt / equity
0.81×
This company
0.62×
Market median
+31% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KC Deputy Member | Deputy Member | 2012 |
HA Chief Executive Officer | Chief Executive Officer | 2012 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Holding Syv8seks As
SYV8SEKS AS Board members of SYV8SEKS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kamran Choudhry Younas | Deputy Member | 0 companies |
| Humera Anwar | Chief Executive Officer | 0 companies |